bluebird bio, Inc.bluebird bio, Inc.bluebird bio, Inc.

bluebird bio, Inc.

No trades
See on Supercharts
Market capitalization
‪183.80 M‬USD
−0.7436USD
‪29.50 M‬USD
‪189.83 M‬
Beta (1Y)
2.12

About bluebird bio, Inc.

CEO
Andrew Obenshain
Headquarters
Somerville
Founded
1992
FIGI
BBG000QGWY50
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BLUE is 0.9510 USD — it has decreased by 2.02% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange bluebird bio, Inc. stocks are traded under the ticker BLUE.
bluebird bio, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
BLUE stock is 8.45% volatile and has beta coefficient of 2.12. Check out the list of the most volatile stocks — is bluebird bio, Inc. there?
BLUE earnings for the last quarter are −0.66 USD per share, whereas the estimation was −0.67 USD resulting in a 1.29% surprise. The estimated earnings for the next quarter are −0.66 USD per share. See more details about bluebird bio, Inc. earnings.
bluebird bio, Inc. revenue for the last quarter amounts to ‪12.39 M‬ USD despite the estimated figure of ‪13.56 M‬ USD. In the next quarter revenue is expected to reach ‪16.78 M‬ USD.
Yes, you can track bluebird bio, Inc. financials in yearly and quarterly reports right on TradingView.
BLUE stock has fallen by 0.94% compared to the previous week, the month change is a 31.09% fall, over the last year bluebird bio, Inc. has showed a 72.27% decrease.
BLUE net income for the last quarter is ‪−71.73 M‬ USD, while the quarter before that showed ‪−72.91 M‬ USD of net income which accounts for 1.61% change. Track more bluebird bio, Inc. financial stats to get the full picture.
Today bluebird bio, Inc. has the market capitalization of ‪187.08 M‬, it has decreased by 3.71% over the last week.
No, BLUE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BLUE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade bluebird bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BLUE reached its all-time high on Mar 13, 2018 with the price of 152.8828 USD, and its all-time low was 0.8790 USD and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So bluebird bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating bluebird bio, Inc. stock shows the sell signal. See more of bluebird bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on bluebird bio, Inc. future price: according to them, BLUE price has a max estimate of 8.00 USD and a min estimate of 1.00 USD. Read a more detailed bluebird bio, Inc. forecast: see what analysts think of bluebird bio, Inc. and suggest that you do with its stocks.